Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Protocol for a randomised ‘screen-and-treat’ Helicobacter pylori eradication trial in 14–18-years-old adolescents residing in three regions of Chile: effectiveness and microbiological host implications
by
George, Sergio
, Mamani, Nora
, Cabrera, Camila
, Aguilera, Ximena
, Lagomarcino, Anne
, Lucero, Yalda
, Zabala Torres, Beatriz
, O'Ryan, Miguel
, Fernández, Lilian
in
Abdomen
/ Adolescent
/ Adolescents
/ Anti-Bacterial Agents - therapeutic use
/ Antibiotics
/ Antimicrobial agents
/ Asymptomatic
/ Bacteria
/ Biomarkers
/ Breath Tests
/ Childhood
/ Chile
/ Clinical Trial
/ Feces - microbiology
/ Female
/ Gastric cancer
/ Gastrointestinal Microbiome
/ Helicobacter Infections - diagnosis
/ Helicobacter Infections - drug therapy
/ Helicobacter Infections - microbiology
/ Helicobacter pylori - drug effects
/ Helicobacter pylori - isolation & purification
/ Humans
/ Infections
/ Infectious diseases
/ Male
/ Mass Screening - methods
/ Medical ethics
/ Microbiota
/ Mortality
/ Paediatric infectious disease and immunisation
/ Pediatrics
/ Questionnaires
/ Randomized Controlled Trials as Topic
/ Students
/ Teenagers
/ Ulcers
/ Young adults
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Protocol for a randomised ‘screen-and-treat’ Helicobacter pylori eradication trial in 14–18-years-old adolescents residing in three regions of Chile: effectiveness and microbiological host implications
by
George, Sergio
, Mamani, Nora
, Cabrera, Camila
, Aguilera, Ximena
, Lagomarcino, Anne
, Lucero, Yalda
, Zabala Torres, Beatriz
, O'Ryan, Miguel
, Fernández, Lilian
in
Abdomen
/ Adolescent
/ Adolescents
/ Anti-Bacterial Agents - therapeutic use
/ Antibiotics
/ Antimicrobial agents
/ Asymptomatic
/ Bacteria
/ Biomarkers
/ Breath Tests
/ Childhood
/ Chile
/ Clinical Trial
/ Feces - microbiology
/ Female
/ Gastric cancer
/ Gastrointestinal Microbiome
/ Helicobacter Infections - diagnosis
/ Helicobacter Infections - drug therapy
/ Helicobacter Infections - microbiology
/ Helicobacter pylori - drug effects
/ Helicobacter pylori - isolation & purification
/ Humans
/ Infections
/ Infectious diseases
/ Male
/ Mass Screening - methods
/ Medical ethics
/ Microbiota
/ Mortality
/ Paediatric infectious disease and immunisation
/ Pediatrics
/ Questionnaires
/ Randomized Controlled Trials as Topic
/ Students
/ Teenagers
/ Ulcers
/ Young adults
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Protocol for a randomised ‘screen-and-treat’ Helicobacter pylori eradication trial in 14–18-years-old adolescents residing in three regions of Chile: effectiveness and microbiological host implications
by
George, Sergio
, Mamani, Nora
, Cabrera, Camila
, Aguilera, Ximena
, Lagomarcino, Anne
, Lucero, Yalda
, Zabala Torres, Beatriz
, O'Ryan, Miguel
, Fernández, Lilian
in
Abdomen
/ Adolescent
/ Adolescents
/ Anti-Bacterial Agents - therapeutic use
/ Antibiotics
/ Antimicrobial agents
/ Asymptomatic
/ Bacteria
/ Biomarkers
/ Breath Tests
/ Childhood
/ Chile
/ Clinical Trial
/ Feces - microbiology
/ Female
/ Gastric cancer
/ Gastrointestinal Microbiome
/ Helicobacter Infections - diagnosis
/ Helicobacter Infections - drug therapy
/ Helicobacter Infections - microbiology
/ Helicobacter pylori - drug effects
/ Helicobacter pylori - isolation & purification
/ Humans
/ Infections
/ Infectious diseases
/ Male
/ Mass Screening - methods
/ Medical ethics
/ Microbiota
/ Mortality
/ Paediatric infectious disease and immunisation
/ Pediatrics
/ Questionnaires
/ Randomized Controlled Trials as Topic
/ Students
/ Teenagers
/ Ulcers
/ Young adults
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Protocol for a randomised ‘screen-and-treat’ Helicobacter pylori eradication trial in 14–18-years-old adolescents residing in three regions of Chile: effectiveness and microbiological host implications
Journal Article
Protocol for a randomised ‘screen-and-treat’ Helicobacter pylori eradication trial in 14–18-years-old adolescents residing in three regions of Chile: effectiveness and microbiological host implications
2025
Request Book From Autostore
and Choose the Collection Method
Overview
IntroductionGastric cancer is a major global health concern, being the final stage of a long-term process, primarily associated with Helicobacter pylori (H. pylori) infection. Early childhood acquisition of H. pylori with low spontaneous eradication rates underscores the need for preventive measures. Our previous pilot treatment study revealed high eradication rates, favourable tolerance profile and a decline in serum biomarkers indicative of gastric damage in asymptomatic school-aged children. The purpose of this study is to determine the potential benefit of a ‘screen-and-treat’ strategy targeting persistently infected, asymptomatic adolescents. Specific aims are to assess eradication efficacy, its clinical and molecular outcomes and potential clinical and microbiological side effects.Methods and analysisThe screening phase will involve testing 500–1000 asymptomatic adolescents aged 14–18 from three cities in Chile using the urea breath test (UBT) to identify 210 participants with persistent infection. They will proceed to a randomised, non-blinded, controlled trial, receiving either a sequential eradication scheme for H. pylori or no treatment. Follow-up will span up to 24 months post-treatment, involving UBT, gastroenterological assessments and blood and stool sample collections. Concurrently, a subset of 60 uninfected adolescents will undergo matched follow-up. Enzyme-linked immunosorbent assay (ELISA) commercial kits will evaluate gastric damage biomarkers in serum (pepsinogen I and II, gastrin-17, VCAM-1, CXCL13). Stool samples will be employed for Escherichia coli and Enterococcus spp—culture, assessing AMR via the disk diffusion method. H. pylori clarithromycin resistance will be determined by molecular method from stool samples. The gut microbiome will be characterised by amplifying and sequencing the 16S rRNA gene from stool samples, followed by bioinformatics analysis.Ethics and disseminationApproved by the Human Research Ethics Committee at the Faculty of Medicine, University of Chile (073–2022). Findings will be disseminated in peer-reviewed journals and scientific meetings to guide future practices.Trial registration numberNCT05926804.
Publisher
British Medical Journal Publishing Group,BMJ Publishing Group LTD,BMJ Publishing Group
Subject
/ Anti-Bacterial Agents - therapeutic use
/ Bacteria
/ Chile
/ Female
/ Helicobacter Infections - diagnosis
/ Helicobacter Infections - drug therapy
/ Helicobacter Infections - microbiology
/ Helicobacter pylori - drug effects
/ Helicobacter pylori - isolation & purification
/ Humans
/ Male
/ Paediatric infectious disease and immunisation
/ Randomized Controlled Trials as Topic
/ Students
/ Ulcers
This website uses cookies to ensure you get the best experience on our website.